Skip to main content

Table 4 Comparison MDM2 SNP309 allele distribution among oral contraceptive users and non-users between LSIL, HSIL and normal cytology (control)

From: MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives

 

Cases

Controld

SNP 309 rs2278744

Total SILa

LSILb

HSILc

 

Alleles

Yes

No

Total

Yes

No

Total

Yes

No

Total

Yes

No

Total

T

79 (0.58)

175 (0.63)

254 (0.61)

56 (0.57)

109 (0.68)

165 (0.63)

23 (0.60)

66 (0.58)

89 (0.59)

29 (0.60)

63 (0.66)

92 (0.64)

G

57 (0.42)

101 (0.37)

158 (0.39)

42 (0.43)

53 (0.32)

95 (0.37)

15 (0.40)

48 (0.42)

63 (0.41)

19 (0.40)

33 (0.34)

52 (0.36)

Genotypes

            

TT

22 (0.32)

52 (0.38)

74 (0.36)

17 (0.35)

37 (0.46)

54 (0.41)

5 (0.26)

15 (0.27)

20 (0.26)

9 (0.37)

21 (0.44)

30 (0.42)

TG

35 (0.51)

71 (0.51)

106 (0.51)

22 (0.45)

35 (0.43)

57 (0.44)

13 (0.69)

36 (0.63)

49 (0.64)

11 (0.46)

21 (0.44)

32 (0.44)

GG

11 (0.17)

15 (0.11)

26 (0.13)

10 (0.20)

9 (0.11)

19 (0.15)

1 (0.05)

6 (0.10)

7 (0.10)

4 (0.17)

6 (0.12)

10 (0.14)

  1. aSIL: Squamous intraepithelial lesions.
  2. bLSIL: Low-grade squamous intraepithelial lesions.
  3. cHSIL: High-grade squamous intraepithelial lesions.
  4. dControl: Normal cytology.